Zacks Research Issues Negative Estimate for THC Earnings

Tenet Healthcare Co. (NYSE:THC - Free Report) - Zacks Research reduced their Q2 2026 earnings per share estimates for shares of Tenet Healthcare in a report released on Wednesday, March 26th. Zacks Research analyst R. Department now anticipates that the company will earn $3.33 per share for the quarter, down from their previous estimate of $3.34. The consensus estimate for Tenet Healthcare's current full-year earnings is $12.24 per share. Zacks Research also issued estimates for Tenet Healthcare's Q3 2026 earnings at $3.08 EPS.

Tenet Healthcare (NYSE:THC - Get Free Report) last released its quarterly earnings results on Wednesday, February 12th. The company reported $3.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.95 by $0.49. Tenet Healthcare had a return on equity of 21.88% and a net margin of 15.48%.

A number of other equities research analysts have also issued reports on THC. The Goldman Sachs Group lowered shares of Tenet Healthcare from a "buy" rating to a "neutral" rating and cut their price target for the company from $196.00 to $140.00 in a report on Monday, December 16th. TD Cowen assumed coverage on shares of Tenet Healthcare in a research report on Wednesday, February 26th. They set a "buy" rating and a $175.00 price objective on the stock. Barclays decreased their target price on shares of Tenet Healthcare from $190.00 to $161.00 and set an "overweight" rating for the company in a research note on Thursday, February 13th. Morgan Stanley assumed coverage on Tenet Healthcare in a report on Wednesday, March 26th. They set an "overweight" rating and a $165.00 price objective for the company. Finally, Truist Financial dropped their target price on Tenet Healthcare from $190.00 to $175.00 and set a "buy" rating on the stock in a research report on Monday, January 6th. Three investment analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, Tenet Healthcare currently has an average rating of "Moderate Buy" and a consensus price target of $166.41.

Remove Ads

Tenet Healthcare Price Performance

Shares of NYSE THC traded down $3.20 during mid-day trading on Monday, reaching $133.98. The company had a trading volume of 603,520 shares, compared to its average volume of 1,471,353. The company has a 50-day moving average price of $132.55 and a two-hundred day moving average price of $141.91. The company has a current ratio of 1.78, a quick ratio of 1.70 and a debt-to-equity ratio of 2.25. The stock has a market cap of $12.74 billion, a PE ratio of 4.16, a P/E/G ratio of 1.02 and a beta of 2.06. Tenet Healthcare has a 1-year low of $90.03 and a 1-year high of $171.20.

Insider Activity at Tenet Healthcare

In related news, Director J Robert Kerrey sold 9,525 shares of the firm's stock in a transaction that occurred on Tuesday, March 11th. The stock was sold at an average price of $125.43, for a total transaction of $1,194,720.75. Following the completion of the transaction, the director now owns 27,378 shares in the company, valued at $3,434,022.54. This trade represents a 25.81 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 0.93% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Tenet Healthcare

A number of institutional investors and hedge funds have recently added to or reduced their stakes in THC. Coldstream Capital Management Inc. lifted its position in Tenet Healthcare by 2.2% during the 3rd quarter. Coldstream Capital Management Inc. now owns 3,406 shares of the company's stock worth $566,000 after buying an additional 74 shares in the last quarter. EverSource Wealth Advisors LLC boosted its holdings in Tenet Healthcare by 9.3% in the fourth quarter. EverSource Wealth Advisors LLC now owns 940 shares of the company's stock valued at $119,000 after acquiring an additional 80 shares during the last quarter. GeoWealth Management LLC lifted its holdings in Tenet Healthcare by 39.8% in the fourth quarter. GeoWealth Management LLC now owns 295 shares of the company's stock valued at $37,000 after buying an additional 84 shares during the period. Spire Wealth Management lifted its stake in Tenet Healthcare by 19.5% in the fourth quarter. Spire Wealth Management now owns 558 shares of the company's stock valued at $70,000 after buying an additional 91 shares during the period. Finally, CIBC Private Wealth Group LLC increased its stake in Tenet Healthcare by 1.7% in the fourth quarter. CIBC Private Wealth Group LLC now owns 5,619 shares of the company's stock valued at $732,000 after purchasing an additional 92 shares in the last quarter. 95.44% of the stock is currently owned by institutional investors and hedge funds.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.